New antiarrhythmic agents.
D000638:Amiodarone / Q000009:adverse effects / Q000378:metabolism; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005424:Flecainide; D006801:Humans; D007700:Kinetics; D008801:Mexiletine / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D010353:Patient Education as Topic; D010880:Piperidines / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D010880:Piperidines; D008801:Mexiletine; D005424:Flecainide; D000638:Amiodarone